Calcium/calmodulin kinase IV (CaMKIV) is activated in T cells from SLE patients and MRL/lpr mice (191–193), and promotes the differentiation of Th17 cells and IL-17 production by activating the Akt/mTOR pathway (130). Here, IL17A is linked to systemic lupus erythematosus.